News

Filter

Auxilium and SOBI collaborate on Xiapex

16-07-2013

USA-based Auxilium Pharmaceuticals (Nasdaq: AUXL) and Swedish Orphan Biovitrum (STO: SOBI) have entered…

Auxilium PharmaceuticalsEuropeLicensingPharmaceuticalRare diseasesRest of the WorldSwedish Orphan BiovitrumXiapex

Protalix gains Israeli approval for Gaucher drug Elelyso

01-10-2012

ael-based Protalix BioTherapeutics (NYSE-AMEX: OLX) has received marketing authorization from the Israeli…

BiotechnologyElelysoPharmaceuticalProtalix BioTherapeuticsRare diseasesRegulationRest of the World

Pharming extends Ruconest deal with SOBI

16-08-2011

Netherlands-based biotech firm Pharming Group NV (Euronext: PHARM) has extended its existing agreement…

BiotechnologyEuropeLicensingPharmaceuticalPharmingRare diseasesRest of the WorldRhucinRuconestSwedish Orphan Biovitrum

South Africa first government to use the Pool for Open Innovation to stimulate neglected disease drug R&D

06-05-2010

South Africa's Technology Innovation Agency (TIA) yesterday became the first government agency to join…

Alnylam PharmaceuticalsGlaxoSmithKlinePharmaceuticalRare diseasesResearchRest of the WorldTropical diseases

COMPANY SPOTLIGHT

Menarini

Back to top